PortfoliosLab logo

Ambrx Biopharma Inc. (AMAM)

Equity · Currency in USD · Last updated Sep 24, 2022

Company Info

ISINUS02290A1025
CUSIP02290A102
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.11
Year Range$1.11 - $13.91
EMA (50)$2.01
EMA (200)$5.23
Average Volume$34.14K
Market Capitalization$43.99M

AMAMShare Price Chart


Chart placeholderClick Calculate to get results

AMAMPerformance

The chart shows the growth of $10,000 invested in Ambrx Biopharma Inc. in Jun 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $621 for a total return of roughly -93.79%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-76.10%
-20.26%
AMAM (Ambrx Biopharma Inc.)
Benchmark (^GSPC)

AMAMReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-44.88%-10.55%
6M-77.09%-18.29%
YTD-88.28%-22.51%
1Y-92.44%-15.98%
5Y-88.87%-9.08%
10Y-88.87%-9.08%

AMAMMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-46.40%-7.23%-8.24%-7.52%3.15%-32.57%4.91%-40.65%-35.85%
202114.96%-0.26%-8.90%-24.20%-6.67%-25.79%-3.42%

AMAMSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Ambrx Biopharma Inc. Sharpe ratio is -1.32. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.40-1.20-1.00-0.80-0.60-0.40-0.20Jun 26Jul 03Jul 10Jul 17Jul 24Jul 31Aug 07Aug 14Aug 21Aug 28Sep 04Sep 11Sep 18
-1.32
-0.78
AMAM (Ambrx Biopharma Inc.)
Benchmark (^GSPC)

AMAMDividend History


Ambrx Biopharma Inc. doesn't pay dividends

AMAMDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-95.30%
-23.00%
AMAM (Ambrx Biopharma Inc.)
Benchmark (^GSPC)

AMAMWorst Drawdowns

The table below shows the maximum drawdowns of the Ambrx Biopharma Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Ambrx Biopharma Inc. is 95.30%, recorded on Sep 23, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.3%Jul 14, 2021303Sep 23, 2022
-6.45%Jun 21, 20212Jun 22, 20213Jun 25, 20215
-4.08%Jul 1, 20211Jul 1, 20212Jul 6, 20213
-2.47%Jul 9, 20212Jul 12, 20211Jul 13, 20213
-2.27%Jun 28, 20211Jun 28, 20211Jun 29, 20212
-0.15%Jul 7, 20211Jul 7, 20211Jul 8, 20212

AMAMVolatility Chart

Current Ambrx Biopharma Inc. volatility is 38.20%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%AprilMayJuneJulyAugustSeptember
38.20%
23.28%
AMAM (Ambrx Biopharma Inc.)
Benchmark (^GSPC)